ELVN
ENLIVEN THERP (ELVN)
NASDAQ
$54.33+$0.005 (+0.009%)
Price as of Sep 11, 2026 7:56 PM EDT
  • $4.0B
    Market Cap
  • 172.14%
    1-Year Change
  • Biotechnology
    Industry

Top Holders

Institutional
Mutual Funds
Holder
Ownership %
Shares Held
Change (Shares, %)
Report Date
FMR LLC
14.03%
10.0M
+3.2M (+31.88%)
Jun 30, 2026
ORBIMED ADVISORS LLC
9.49%
6.8M
-1.2M (-17.46%)
Jun 30, 2026
POLAR CAPITAL HOLDINGS PLC
9.00%
6.4M
+1.4M (+21.22%)
Jun 30, 2026
BLACKROCK, INC.
6.10%
4.4M
+674,997 (+15.48%)
Jun 30, 2026
VESTAL POINT CAPITAL, LP
5.60%
4.0M
+750,000 (+18.75%)
Jun 30, 2026
COMMODORE CAPITAL LP
4.58%
3.3M
0 (0.00%)
Jun 30, 2026
BLACKROCK FUNDING, INC. /DE
4.15%
3.0M
+28,486 (+0.96%)
Dec 31, 2024

Current Ownership Distribution

  • Institutions425.9M (78.50%)
  • Mutual Funds105.6M (19.47%)
  • Insiders11.0M (2.03%)
  • Other0 (0.00%)

Insider Transactions

  • 2.03% (11.0M)
    Current InsiderOwnership (%, shares)
  • 0
    Number of InsiderBuying (last 12 months)
  • $0.00
    Amount of InsiderBuying (last 12 months)
  • 9
    Number of InsiderSelling (last 12 months)
  • $1.3B
    Amount of InsiderSelling (last 12 months)
Insider Name & Title
Type
Date
Transaction Value
Shares
Share Price
Shares After Transactions
Hohl Benjamin
CHIEF FINANCIAL OFFICER
Sell
Aug 17, 2026
$270,168.37
4,630
$58.35
41,424
Collins Helen Louise
CHIEF MEDICAL OFFICER
Exempt
Aug 17, 2026
$0.00
5,000
$0.00
111,268
Hohl Benjamin
CHIEF FINANCIAL OFFICER
Sell
Aug 17, 2026
$82,382.80
1,388
$59.35
40,036
Collins Helen Louise
CHIEF MEDICAL OFFICER
Exempt
Aug 17, 2026
$12,400.00
5,000
$2.48
30,000
Collins Helen Louise
CHIEF MEDICAL OFFICER
Sell
Aug 17, 2026
$227,649.63
3,900
$58.37
26,100
Collins Helen Louise
CHIEF MEDICAL OFFICER
Sell
Aug 17, 2026
$65,281.15
1,100
$59.35
25,000
Derynck Mika K
Exempt
Aug 04, 2026
$0.00
87,373
$0.00
0
Derynck Mika K
Exempt
Aug 04, 2026
$0.00
27,567
$0.00
0
Derynck Mika K
Exempt
Aug 04, 2026
$0.00
23,364
$0.00
0
Derynck Mika K
Exempt
Aug 04, 2026
$0.00
20,491
$0.00
0
Derynck Mika K
Exempt
Aug 04, 2026
$216,685.04
87,373
$2.48
87,373
Derynck Mika K
Exempt
Aug 04, 2026
$696,893.76
27,567
$25.28
114,940
Derynck Mika K
Exempt
Aug 04, 2026
$346,955.40
23,364
$14.85
138,304
Derynck Mika K
Exempt
Aug 04, 2026
$460,432.77
20,491
$22.47
158,795
Derynck Mika K
Sell
Aug 04, 2026
$9.6M
158,795
$60.21
0
Hohl Benjamin
CHIEF FINANCIAL OFFICER
Exempt
Jul 17, 2026
$0.00
1,072
$0.00
84,966
Hohl Benjamin
CHIEF FINANCIAL OFFICER
Exempt
Jul 17, 2026
$2,658.56
1,072
$2.48
52,072
Hohl Benjamin
CHIEF FINANCIAL OFFICER
Sell
Jul 17, 2026
$16,190.77
324
$49.97
51,748
Hohl Benjamin
CHIEF FINANCIAL OFFICER
Sell
Jul 17, 2026
$18,996.97
369
$51.48
51,379
Hohl Benjamin
CHIEF FINANCIAL OFFICER
Sell
Jul 17, 2026
$134,143.35
2,564
$52.32
48,815
Hohl Benjamin
CHIEF FINANCIAL OFFICER
Sell
Jul 17, 2026
$140,823.04
2,638
$53.38
46,177
Hohl Benjamin
CHIEF FINANCIAL OFFICER
Sell
Jul 17, 2026
$6,626.21
123
$53.87
46,054
Kunkel Lori Anne
Sell
Jul 06, 2026
$205,481.76
4,111
$49.98
47,773
Kunkel Lori Anne
Sell
Jul 06, 2026
$299,421.49
5,889
$50.84
41,884
ORBIMED ADVISORS LLC
Sell
Jun 22, 2026
$1.1M
24,846
$45.38
220,882
ORBIMED ADVISORS LLC
Sell
Jun 22, 2026
$66,465.00
1,477
$45.00
219,405
ORBIMED ADVISORS LLC
Sell
Jun 22, 2026
$35.7M
787,024
$45.38
6.6M
ORBIMED ADVISORS LLC
Sell
Jun 22, 2026
$2.1M
46,776
$45.00
6.6M
Collins Helen Louise
CHIEF MEDICAL OFFICER
Exempt
Jun 17, 2026
$0.00
5,000
$0.00
121,268
Collins Helen Louise
CHIEF MEDICAL OFFICER
Exempt
Jun 17, 2026
$12,400.00
5,000
$2.48
30,000